---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-038113"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2024-09-25T23:59:59+00:00"
generated_at: "2026-05-31T01:49:22.169957+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Evofem Biosciences sells $260k Series F-1 Preferred Stock to Aditxt in private placement

## Summary
- Sold 260 shares of Series F-1 Preferred Stock to Aditxt for $260,000 on September 20, 2024.
- Preferred shares are convertible into common stock; registration rights agreement requires filing within 300 days.
- Private placement is part of consideration under the Amended Merger Agreement with Aditxt (previously disclosed).
- Securities issued in reliance on Section 4(a)(2) exemption from registration under the Securities Act.
- Company must use best efforts to have registration statement declared effective within 90 days of filing.

## SEC filing metadata
- accession: 0001493152-24-038113
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2024-09-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000149315224038113/0001493152-24-038113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000149315224038113/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-038113
- JSON: https://secwatch.observer/filing/0001493152-24-038113.json
- Plain text: https://secwatch.observer/filing/0001493152-24-038113.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.